We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Antitrust, Market Exclusivity, and Transparency in the Pharmaceutical Industry.
- Authors
Sinha, Michael S.; Curfman, Gregory D.; Carrier, Michael A.
- Abstract
This Viewpoint uses 3 recent legal antitrust cases filed by pharmaceutical companies against each other to identify mechanisms by which companies suppress competition and keep drug prices inflated, and emphasizes the role of antitrust law as a potentially positive means to open markets and increase access to affordable drugs.
- Subjects
UNITED States; PHARMACEUTICAL industry; ANTITRUST violation lawsuits; ANTITRUST lawsuits; ORGANIZATIONAL transparency; DRUG prices; INDUSTRIAL laws &; legislation; INDUSTRIES &; economics; MEDICAL care cost laws; GENERIC drugs; ECONOMIC competition laws; ANTITRUST law; BIOLOGICAL products; COMPARATIVE studies; PHARMACEUTICAL services insurance; RESEARCH methodology; MEDICAL cooperation; RESEARCH; STATE governments; EVALUATION research; ECONOMICS
- Publication
JAMA: Journal of the American Medical Association, 2018, Vol 319, Issue 22, p2271
- ISSN
0098-7484
- Publication type
journal article
- DOI
10.1001/jama.2018.3478